Contact
Please use this form to send email to PR contact of this press release:
Kinder Holding Corp. Receives FINRA Approval for Name Change to Intiva BioPharma Inc.
TO:
Mark Lubchenco
Kinder Holding/Intiva BioPharma Inc.
303-431-4530